The New Jersey Alliance for Clinical and Translational Science (NJ ACTS) is delighted to announce the next cycle
of its Clinical-Translational Scientist Junior Faculty Award Program (K12), supported by a grant from the
National Institutes of Health/National Center for Advancing Translational Sciences.
The K12 program supports Scholars in developing and conducting outstanding clinical-translational research projects
at any one of the NJ ACTS partner institutions–Rutgers, New Jersey Institute of Technology (NJIT), and
RWJBarnabas Health.
Scholars can receive up to two years of support with sufficient progress. Successful candidates will receive K12
appointments starting September 1, 2026.